Neurothreads: Development of supportive carriers for mature dopaminergic neuron differentiation and implantation.

[1]  S. Khoshnam,et al.  Human Pluripotent Stem Cells in Neurodegenerative Diseases: Potentials, Advances, and Limitations. , 2020, Current stem cell research & therapy.

[2]  Harald Sontheimer.  Parkinson Disease , 2020, Diseases of the Nervous System.

[3]  P. Moghe,et al.  Peptide-based scaffolds for the culture and transplantation of human dopaminergic neurons. , 2020, Tissue engineering. Part A.

[4]  O. Naveiras,et al.  Injectable, scalable 3D tissue-engineered model of marrow hematopoiesis. , 2019, Biomaterials.

[5]  Amos Bairoch,et al.  The neXtProt knowledgebase in 2020: data, tools and usability improvements , 2019, Nucleic Acids Res..

[6]  Zachary J. Rogers,et al.  Injectable Cryogels for Biomedical Applications. , 2019, Trends in biotechnology.

[7]  P. Fishman,et al.  The role of high‐intensity focused ultrasound as a symptomatic treatment for Parkinson's disease , 2019, Movement disorders : official journal of the Movement Disorder Society.

[8]  Yun-Wen Zheng,et al.  Predicting differentiation potential of human pluripotent stem cells: Possibilities and challenges , 2019, World journal of stem cells.

[9]  Lu Zhang,et al.  Co-transplantation of Epidermal Neural Crest Stem Cells and Olfactory Ensheathing Cells Repairs Sciatic Nerve Defects in Rats , 2019, Front. Cell. Neurosci..

[10]  Amit Agrawal,et al.  Estimating the global incidence of traumatic brain injury. , 2019, Journal of neurosurgery.

[11]  A. Teixeira,et al.  Stem cells in animal models of Huntington disease: A systematic review , 2019, Molecular and Cellular Neuroscience.

[12]  A. Pandit,et al.  Encapsulation of young donor age dopaminergic grafts in a GDNF‐loaded collagen hydrogel further increases their survival, reinnervation, and functional efficacy after intrastriatal transplantation in hemi‐Parkinsonian rats , 2019, The European journal of neuroscience.

[13]  J. Takahashi.  Preparing for first human trial of induced pluripotent stem cell-derived cells for Parkinson's disease: an interview with Jun Takahashi. , 2019, Regenerative medicine.

[14]  Sung-Rae Cho,et al.  Cell Surface Antigen Display for Neuronal Differentiation-Specific Tracking , 2018, Biomolecules & therapeutics.

[15]  Evan W. Miller,et al.  Dopaminergic Neurons Transplanted Using Cell‐Instructive Biomaterials Alleviate Parkinsonism in Rodents , 2018, Advanced Functional Materials.

[16]  Dong Kyu Lee,et al.  What is the proper way to apply the multiple comparison test? , 2018, Korean journal of anesthesiology.

[17]  C. Tanner,et al.  Prevalence of Parkinson’s disease across North America , 2018, npj Parkinson's Disease.

[18]  P. Renaud,et al.  Additive manufacturing of hierarchical injectable scaffolds for tissue engineering. , 2018, Acta biomaterialia.

[19]  D. K. Cullen,et al.  Tissue engineered nigrostriatal pathway for treatment of Parkinson's disease , 2018, Journal of tissue engineering and regenerative medicine.

[20]  P. Renaud,et al.  Pore Size Manipulation in 3D Printed Cryogels Enables Selective Cell Seeding , 2018 .

[21]  A. Pandit,et al.  Encapsulation of primary dopaminergic neurons in a GDNF-loaded collagen hydrogel increases their survival, re-innervation and function after intra-striatal transplantation , 2017, Scientific Reports.

[22]  Malin Parmar,et al.  Human Trials of Stem Cell-Derived Dopamine Neurons for Parkinson's Disease: Dawn of a New Era. , 2017, Cell stem cell.

[23]  A. Heuer,et al.  Generation of high-purity human ventral midbrain dopaminergic progenitors for in vitro maturation and intracerebral transplantation , 2017, Nature Protocols.

[24]  Satoshi Morita,et al.  Human iPS cell-derived dopaminergic neurons function in a primate Parkinson’s disease model , 2017, Nature.

[25]  Evan W. Miller,et al.  Engineered hydrogels increase the post-transplantation survival of encapsulated hESC-derived midbrain dopaminergic neurons. , 2017, Biomaterials.

[26]  Jason L. Green,et al.  Transdifferentiation and reprogramming: Overview of the processes, their similarities and differences. , 2017, Biochimica et biophysica acta. Molecular cell research.

[27]  R. Hoogenboom,et al.  Cytotoxicity of polycations: Relationship of molecular weight and the hydrolytic theory of the mechanism of toxicity. , 2017, International journal of pharmaceutics.

[28]  A. Björklund,et al.  Replacing Dopamine Neurons in Parkinson’s Disease: How did it happen? , 2017, Journal of Parkinson's disease.

[29]  Jörg Steinbach,et al.  Cryogel-supported stem cell factory for customized sustained release of bispecific antibodies for cancer immunotherapy , 2017, Scientific Reports.

[30]  K. Krause,et al.  Elimination of proliferating cells from CNS grafts using a Ki67 promoter-driven thymidine kinase , 2016, Molecular therapy. Methods & clinical development.

[31]  D. Fass,et al.  Cross-linking reveals laminin coiled-coil architecture , 2016, Proceedings of the National Academy of Sciences.

[32]  L. Laurent,et al.  Neural Stem Cells Derived from Human Parthenogenetic Stem Cells Engraft and Promote Recovery in a Nonhuman Primate Model of Parkinson's Disease , 2016, Cell transplantation.

[33]  Tetsuhiro Kikuchi,et al.  Purification of functional human ES and iPSC-derived midbrain dopaminergic progenitors using LRTM1 , 2016, Nature Communications.

[34]  S. Carmichael,et al.  Systematic optimization of an engineered hydrogel allows for selective control of human neural stem cell survival and differentiation after transplantation in the stroke brain. , 2016, Biomaterials.

[35]  C. Borlongan.  Preliminary Reports of Stereotaxic Stem Cell Transplants in Chronic Stroke Patients. , 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

[36]  Magdalena Götz,et al.  Direct neuronal reprogramming: learning from and for development , 2016, Development.

[37]  Marius Wernig,et al.  Generation and transplantation of reprogrammed human neurons in the brain using 3D microtopographic scaffolds , 2016, Nature Communications.

[38]  D. K. Cullen,et al.  Advanced biomaterial strategies to transplant preformed micro-tissue engineered neural networks into the brain , 2016, Journal of neural engineering.

[39]  R. Awatramani,et al.  Molecular heterogeneity of midbrain dopaminergic neurons – Moving toward single cell resolution , 2015, FEBS letters.

[40]  G. Augustine,et al.  Synapsin Isoforms and Synaptic Vesicle Trafficking , 2015, Molecules and cells.

[41]  D. K. Cullen,et al.  Rebuilding Brain Circuitry with Living Micro-Tissue Engineered Neural Networks. , 2015, Tissue engineering. Part A.

[42]  B. Newland,et al.  Tackling Cell Transplantation Anoikis: An Injectable, Shape Memory Cryogel Microcarrier Platform Material for Stem Cell and Neuronal Cell Growth. , 2015, Small.

[43]  B. Gentil,et al.  Neurofilament dynamics and involvement in neurological disorders , 2015, Cell and Tissue Research.

[44]  A. Björklund,et al.  Human ESC-Derived Dopamine Neurons Show Similar Preclinical Efficacy and Potency to Fetal Neurons when Grafted in a Rat Model of Parkinson’s Disease , 2014, Cell stem cell.

[45]  O. B. Ozdoganlar,et al.  Chronic tissue response to carboxymethyl cellulose based dissolvable insertion needle for ultra-small neural probes. , 2014, Biomaterials.

[46]  Xinzhong Dong,et al.  Generation of multipotent induced neural crest by direct reprogramming of human postnatal fibroblasts with a single transcription factor. , 2014, Cell stem cell.

[47]  Aya Abou Hammoud,et al.  The Oct4 protein: more than a magic stemness marker. , 2014, American journal of stem cells.

[48]  I. Weissman,et al.  Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies , 2013, Nature Medicine.

[49]  F. Auger,et al.  The pivotal role of vascularization in tissue engineering. , 2013, Annual review of biomedical engineering.

[50]  Marcel Leist,et al.  Generation of genetically-modified human differentiated cells for toxicological tests and the study of neurodegenerative diseases. , 2013, ALTEX.

[51]  David J Mooney,et al.  Injectable preformed scaffolds with shape-memory properties , 2012, Proceedings of the National Academy of Sciences.

[52]  K. Tominaga-Yoshino,et al.  A simplified method to generate serotonergic neurons from mouse embryonic stem and induced pluripotent stem cells , 2012, Journal of neurochemistry.

[53]  O. Lindvall,et al.  Generation of regionally specified neural progenitors and functional neurons from human embryonic stem cells under defined conditions. , 2012, Cell reports.

[54]  D. Surmeier,et al.  Floor plate-derived dopamine neurons from hESCs efficiently engraft in animal models of PD , 2011, Nature.

[55]  Tanja Waldmann,et al.  Rapid, complete and large‐scale generation of post‐mitotic neurons from the human LUHMES cell line , 2011, Journal of neurochemistry.

[56]  Anna Sarnowska,et al.  The performance of laminin-containing cryogel scaffolds in neural tissue regeneration. , 2011, Biomaterials.

[57]  G. Lajoie,et al.  Matrigel: A complex protein mixture required for optimal growth of cell culture , 2010, Proteomics.

[58]  V. Orlov,et al.  Controlled adsorption-desorption of cationic polymers on the surface of anionic latex particles , 2010 .

[59]  Thomas Vierbuchen,et al.  Direct conversion of fibroblasts to functional neurons by defined factors , 2010, Nature.

[60]  Stanley Fahn,et al.  Dopamine Cell Implantation in Parkinson's Disease: Long-Term Clinical and 18F-FDOPA PET Outcomes , 2010, Journal of Nuclear Medicine.

[61]  J. Roh,et al.  Stem Cells Transplantation and Huntington's Disease. , 2009, International journal of stem cells.

[62]  C. Warren Olanow,et al.  The scientific and clinical basis for the treatment of Parkinson disease (2009) , 2009, Neurology.

[63]  S. Cullheim,et al.  Integrin-laminin interactions controlling neurite outgrowth from adult DRG neurons in vitro , 2008, Molecular and Cellular Neuroscience.

[64]  A. Arkudas,et al.  To matrigel or not to matrigel. , 2008, The American journal of pathology.

[65]  E. Blennow,et al.  Mechanical isolation of the inner cell mass is effective in derivation of new human embryonic stem cell lines. , 2007, Human reproduction.

[66]  R. Fernández-Lafuente,et al.  Chemical modification of protein surfaces to improve their reversible enzyme immobilization on ionic exchangers. , 2006, Biomacromolecules.

[67]  Lorraine Iacovitti,et al.  Purified mouse dopamine neurons thrive and function after transplantation into brain but require novel glial factors for survival in culture , 2005, Molecular and Cellular Neuroscience.

[68]  F. Camacho,et al.  Microtubule-associated protein 2, a marker of neuronal differentiation, induces mitotic defects, inhibits growth of melanoma cells, and predicts metastatic potential of cutaneous melanoma. , 2005, The American journal of pathology.

[69]  P. Arlotta,et al.  The repair of complex neuronal circuitry by transplanted and endogenous precursors , 2004, NeuroRX.

[70]  G. Gillies,et al.  A realistic brain tissue phantom for intraparenchymal infusion studies. , 2004, Journal of neurosurgery.

[71]  Mahendra Rao,et al.  SOX2, a Persistent Marker for Multipotential Neural Stem Cells Derived from Embryonic Stem Cells, the Embryo or the Adult , 2004, Developmental Neuroscience.

[72]  F. Speleman,et al.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.

[73]  S. Kügler,et al.  Neuron-Specific Expression of Therapeutic Proteins: Evaluation of Different Cellular Promoters in Recombinant Adenoviral Vectors , 2001, Molecular and Cellular Neuroscience.

[74]  D. Mason,et al.  Double immunofluorescence labelling of routinely processed paraffin sections , 2000, The Journal of pathology.

[75]  Johannes Gerdes,et al.  The Ki‐67 protein: From the known and the unknown , 2000, Journal of cellular physiology.

[76]  C. Parish,et al.  Fluorescent dyes for lymphocyte migration and proliferation studies , 1999, Immunology and cell biology.

[77]  J G Parnavelas,et al.  Collagen type IV promotes the differentiation of neuronal progenitors and inhibits astroglial differentiation in cortical cell cultures. , 1998, Brain research. Developmental brain research.

[78]  D. Veal,et al.  Flow cytometry and cell sorting for yeast viability assessment and cell selection , 1998, Yeast.

[79]  M C LaPlaca,et al.  An in vitro model of traumatic neuronal injury: loading rate-dependent changes in acute cytosolic calcium and lactate dehydrogenase release. , 1997, Journal of neurotrauma.

[80]  Y Wang,et al.  Constructing a New Nigrostriatal Pathway in the Parkinsonian Model with Bridged Neural Transplantation in Substantia Nigra , 1996, The Journal of Neuroscience.

[81]  M. Aickin,et al.  Adjusting for multiple testing when reporting research results: the Bonferroni vs Holm methods. , 1996, American journal of public health.

[82]  G. Thiel,et al.  Synapsin I, Synapsin II, and Synaptophysin: Marker Proteins of Synaptic Vesicles , 1993, Brain pathology.

[83]  P. De Camilli,et al.  The distribution of synapsin I and synaptophysin in hippocampal neurons developing in culture , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[84]  H. Buettner,et al.  Quantitative effects of laminin concentration on neurite outgrowth in vitro. , 1991, Developmental biology.

[85]  M. Wilchek,et al.  Limitations of N-hydroxysuccinimide esters in affinity chromatography and protein immobilization. , 1987, Biochemistry.

[86]  L. Liotta,et al.  Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma. , 1982, Biochemistry.

[87]  D E Koshland,et al.  A method for the quantitative modification and estimation of carboxylic acid groups in proteins. , 1967, The Journal of biological chemistry.

[88]  C. Dunnett.  A Multiple Comparison Procedure for Comparing Several Treatments with a Control , 1955 .

[89]  I. Langmuir.  THE ADSORPTION OF GASES ON PLANE SURFACES OF GLASS, MICA AND PLATINUM. , 1918 .

[90]  D. Nisbet,et al.  Functionalized composite scaffolds improve the engraftment of transplanted dopaminergic progenitors in a mouse model of Parkinson's disease. , 2016, Biomaterials.

[91]  D. Mooney,et al.  A Compressible Scaffold for Minimally Invasive Delivery of Large Intact Neuronal Networks , 2015, Advanced healthcare materials.

[92]  P. Brundin,et al.  Neural grafting in Parkinson's disease Problems and possibilities. , 2010, Progress in brain research.

[93]  F. Fändrich,et al.  Derivation, maintenance, and characterization of rat embryonic stem cells in vitro. , 2006, Methods in molecular biology.

[94]  P. A. Roberts.  Early Stages of Nervous System Development , 1991 .

[95]  M. Longair,et al.  Bioinformatics Applications Note Systems Biology Simple Neurite Tracer: Open Source Software for Reconstruction, Visualization and Analysis of Neuronal Processes , 2022 .